CCR4 antagonist (ChemoCentryx)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCCR4 antagonist (ChemoCentryx)
Drug Alias NameCCR4 antagonist (ChemoCentryx)CCX-6239
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 4 antagonists
TargetsC-C chemokine receptor type 4
Therapy Area/IndicationsAutoimmune DiseasesDermatitis, AtopicLung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChemocentryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChemocentryx Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesDermatitis, AtopicLung Diseases

Other Information

ATC CodeN/A
Related LinksN/A